Clinical Scorecard: What Reviews May Miss About Prolonged Grief Disorder
At a Glance
| Category | Detail |
|---|---|
| Condition | Prolonged Grief Disorder (PGD) |
| Key Mechanisms | Grounded in dual process coping, attachment, self-determination, and emotion regulation theories. |
| Target Population | Individuals aged 20 to 93 years experiencing prolonged grief. |
| Care Setting | Clinical settings providing psychotherapy and bereavement interventions. |
Key Highlights
- 71% response rate for PGD-specific interpersonal psychotherapy in clinical trials.
- Moderate strength of evidence for psychotherapy's positive effects on grief symptoms.
- PGD is recognized in DSM-5-TR and ICD-11 with validated diagnostic tools.
- PG-13–Revised scale score of 30 or higher indicates need for PGD-specific treatment.
- Digital grief interventions show promise with sustained effects at 3-month follow-up.
Guideline-Based Recommendations
Diagnosis
- Use PG-13–Revised scale for assessment of PGD.
Management
- Implement PGD-specific psychotherapy interventions.
Monitoring & Follow-up
- Evaluate treatment response and symptom reduction over time.
Risks
- Potential dilution of evidence for PGD-specific therapies due to heterogeneous study grouping.
Patient & Prescribing Data
Adults aged 20 to 93 years experiencing prolonged grief.
Targeted psychotherapy has shown efficacy in randomized trials.
Clinical Best Practices
- Differentiate PGD-specific interventions from general grief therapies in systematic reviews.
- Consider digital interventions as adjuncts to traditional therapies.
Related Resources & Content
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
